ADTX
PINK Aditxt, Inc.$0.0032 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0032, and at the day’s high of $0.0035
- YTD change
- -100.00%
- vs 20-day SMA
- -41.34%
- vs 200-day SMA
- -100.00%
Price ranges
Price & Performance
-0.59 (-99.46%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $1,470,580.0000
- ADTX is down 100% since the beginning of the year
- ADTX is down 100% over the past 12 months
- ADTX is down 56% over the past 1 month
- 0% of all ADTX investors are betting against ADTX
ADTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -99.6%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0001
- Last 5 days
- -28.89%
- vs 8-day SMA
- -23.58%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Mountain View, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.